Sodium Bicarbonate Injection, USP 8.4% - Effective Systemic Alkalinization Treatment
Sodium Bicarbonate Injection, USP 8.4% is a sterile, nonpyrogenic, hypertonic solution designed for intravenous administration. It is primarily used for the correction of metabolic acidosis and other critical conditions requiring systemic alkalinization. This medical-grade solution is essential in managing severe acid-base imbalances in patients.
Key Benefits:
- Systemic Alkalinization: Effectively treats metabolic acidosis by increasing plasma bicarbonate levels, buffering excess hydrogen ions, and raising blood pH.
- Versatile Applications: Indicated for use in severe renal disease, uncontrolled diabetes, cardiac arrest, circulatory insufficiency due to shock or dehydration, and certain drug intoxications.
- Trusted by Healthcare Professionals: Sodium Bicarbonate Injection 8.4% is a preferred choice in emergency settings for its reliable and rapid action in critical care.
Dosage and Administration: Sodium Bicarbonate Injection 8.4% is administered intravenously. In cases of cardiac arrest, an initial dose of one to two 50 mL vials (50 to 100 mEq) is recommended, followed by additional doses as necessary based on blood gas monitoring. The dosage depends on the severity of the acidosis and the patient’s clinical condition.
Why Choose Sodium Bicarbonate Injection 8.4%?
- Rapid Response: Provides quick correction of acidosis in critical care settings, minimizing risks associated with severe metabolic imbalances.
- Comprehensive Care: Ideal for managing electrolyte disturbances in patients with compromised renal function, severe dehydration, or circulatory insufficiency.
Warnings:
- Potential Side Effects: Overly aggressive therapy can result in metabolic alkalosis, hypernatremia, and possible chemical cellulitis at the injection site. In rare cases, rapid injection may cause a decrease in cerebrospinal fluid pressure and intracranial hemorrhage, particularly in neonates and young children.
- Special Precautions: Use with caution in patients with congestive heart failure, severe renal insufficiency, or sodium retention. Continuous monitoring of electrolytes and acid-base balance is essential during treatment.
Storage: Store at 20°C to 25°C (68°F to 77°F), avoiding excessive heat and freezing. Protect from light and keep in a controlled room temperature environment.
Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
